Log In
BCIQ
Print this Print this
 

CS3158

  Manage Alerts
Collapse Summary General Information
Company Shenzhen Chipscreen Biosciences Ltd.
DescriptionSelective VEGFR/HDAC1,2 dual inhibitor
Molecular Target Vascular endothelial growth factor (VEGF) ; Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor; Vascular endothelial growth factor (VEGF) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today